CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Testing an interactive technology in a diverse health literary populationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02020252
NCT02020252N/ACompleted

A Pilot Investigation to Examine the Effect of a Multi-Media, Computer Based Tool (Talking Touchscreen) on Enrollment in Adult Oncology-Specific Clinical Trials at an Academic Medical Center

University of Chicago·observational·Posted Dec 24, 2013·Updated Mar 10, 2021

In Brief

An observational study evaluating Testing an interactive technology in a diverse health literary population for Lung Cancer and 2 related conditions. Completed, enrolled 120 participants across 1 site.

Detailed Summary

The purpose of this research study is to test a touchscreen computer program, which allows patients to see information on a computer screen regarding cancer care, and specifically clinical trials. The purpose of this research is to help the investigators learn more about how to use technology in the medical setting to improve health outcomes.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 24, 2013
Enrollment StartNov 26, 2013
Primary CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 12.5 years ago

Interventions

Testing an interactive technology in a diverse health literary populationbehavioral

Enrollment in therapeutic cancer trials remains low, and is especially challenging for patients with low health literacy. We tested an interactive technology designed for patients with diverse health literacy skills aimed at improving patient receptiveness, willingness, knowledge, self-efficacy and positive attitudes regarding clinical trials.